Alpha Cognition Inc.

ACOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023
Operating Activities
Net Income $-20.7M $-14.8M $-13.8M
Depreciation & Amortization $58.6K $81.2K $84.5K
Depreciation $1.3K $2.1K
Amortization $21.5K $79.9K
Stock-Based Compensation $4.9M $1.1M $2.4M
Net Cash from Operating Activities $-20.4M $-7.8M $-8.8M
Investing Activities
Capital Expenditures $293.5K $26.7K
Business Acquisitions
Net Cash from Investing Activities $-293.5K $-26.7K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $38.2M $54.9M $8.2M
Net Change in Cash $47.1M $-589.1K
Free Cash Flow $-20.7M $-7.8M